Lancet. Retraction?Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

[Giuseppe]

Retraction?Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (The Lancet, edited)

The Lancet, Early Online Publication, 2 February 2010
doi:10.1016/S0140-6736(10)60175-7
Cite or Link Using DOI

Retraction?Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

Original Text

The Editors of The Lancet a

Following the judgment of the UK General Medical Council's Fitness to Practise Panel on Jan 28, 2010, it has become clear that several elements of the 1998 paper by Wakefield et al1 are incorrect, contrary to the findings of an earlier investigation.2 In particular, the claims in the original paper that children were "consecutively referred" and that investigations were "approved" by the local ethics committee have been proven to be false. Therefore we fully retract this paper from the published record.


References

1 Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-641. Summary | Full Text | PDF(758KB) | CrossRef | PubMed
2 Hodgson H. A statement by The Royal Free and University College Medical School and The Royal Free Hampstead NHS Trust. Lancet 2004; 363: 824. Full Text | PDF(37KB) | CrossRef | PubMed

aThe Lancet, London NW1 7BY, UK
-
​

<cite cite="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60175-7/fulltext?_eventId=login">Retraction?Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children : The Lancet</cite>